🇺🇸 FDA
Patent

US 9815796

Pyrimidone carboxamide compounds as PDE2 inhibitors

granted A61PA61P25/18A61P25/22

Quick answer

US patent 9815796 (Pyrimidone carboxamide compounds as PDE2 inhibitors) held by MSD R&D (China) Co. Ltd. expires Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MSD R&D (China) Co. Ltd.
Grant date
Tue Nov 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61P, A61P25/18, A61P25/22, A61P25/28